Analyst firms · Piper Sandler · EW

Piper Sandler EW price target and rating history

Edwards Lifesciences Corporation (EW) · Health Care

Piper Sandler rates Edwards Lifesciences Corporation (EW) Overweight with a $80 price target, as of its latest action on Apr 24, 2025. It has published 4 rating actions on EW since July 2021, including 1 upgrade and 1 downgrade. Across 7 firms with a EW price target in the last 12 months, the median target is $110.

Current rating
Overweight
Price target
$80
Median target, all firms
$110
Actions on EW
4

Piper Sandler price target on EW

$123$102$8020222023202420252026
Piper Sandler price target on EW, each point a stated target, July 2021 to April 2025.

Every Piper Sandler rating on EW

How other firms rate EW

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
Robert W. BairdOutperform$116Nov 5, 2026
Truist SecuritiesBuy$113Nov 4, 2026
BarclaysOverweight$110Oct 7, 2026
UBSBuy$110Jul 28, 2026
Leerink PartnersOutperform$101Jul 24, 2026
Wolfe ResearchOutperform$92Apr 1, 2026
TD CowenBuy$97Jan 9, 2026

Questions about Piper Sandler and EW

What is Piper Sandler's price target for EW?
Piper Sandler's latest stated price target for Edwards Lifesciences Corporation (EW) is $80, from its action on Apr 24, 2025.
What is Piper Sandler's rating on EW?
Piper Sandler rates EW Overweight, a bullish rating, as of Apr 24, 2025.
When did Piper Sandler last change its view on EW?
On Apr 24, 2025, Piper Sandler upgrades to Overweight from Neutral, price target $80.
How does Piper Sandler's EW target compare with other analysts?
Across 7 firms with a EW price target in the last 12 months, the median target is $110.

More EW rating histories

All Piper Sandler ratingsEW news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.